Title of article
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSista
Author/Authors
Charles B Hicks، نويسنده , , Pedro Cahn، نويسنده , , David A Cooper، نويسنده , , Sharon L Walmsley، نويسنده , , Christine Katlama، نويسنده , , Bonaventura Clotet، نويسنده , , Adriano Lazzarin، نويسنده , , Margaret T. Johnson-Selfridge، نويسنده , , Dietmar Neubacher، نويسنده , , Douglas Mayers، نويسنده , , Hernan Valdez ، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
10
From page
466
To page
475
Abstract
Background
Treatment options for HIV-1 infected individuals who have received extensive previous antiretroviral therapy are limited. We compared efficacy and safety of the novel non-peptidic protease inhibitor tipranavir co-administered with ritonavir plu
Journal title
The Lancet
Serial Year
2007
Journal title
The Lancet
Record number
590040
Link To Document